BioAccel

Life365, Inc. operates a virtual care and remote patient monitoring platform designed to facilitate patient management outside traditional healthcare settings. Founded in 2015 and based in Scottsdale, Arizona, the company offers bundled health kits that include pre-paired and pre-configured smart devices, enabling healthcare providers to collect biometric and behavioral data from patients. This platform supports care transitions to home environments, promoting better patient adherence and reducing healthcare costs. Life365's solutions are tailored for various healthcare stakeholders, including Accountable Care Organizations and insurers. The company's strategic partnerships, notably with Microsoft Cloud for Healthcare, enhance its integration capabilities across over 300 health systems, streamlining deployment and improving patient engagement. Life365 has received recognition for its innovations in remote monitoring, holding multiple patents related to AI-driven wearables and other technologies.

Yolia Health, based in Mexico City, specializes in developing innovative medical equipment aimed at preserving, restoring, and enhancing vision. The company has created The True Vision Treatment (TVT), a non-invasive solution designed to address common vision issues such as presbyopia, myopia, and hyperopia. TVT allows patients to self-administer treatment at home using a combination of customized contact lenses and specially formulated eye drops. After only five days of treatment, patients can typically cease using both the contact lenses and eye drops, as well as their reading glasses, for up to 12 months before requiring re-treatment. Notably, Yolia's approach not only corrects near vision but also improves distance vision, distinguishing it from other alternatives on the market. The company is actively seeking sophisticated investors and industry partners to further its mission.

Omni Bioceutical Innovations develops skin and hair treatment solutions tailored to address various dermatological and anti-aging needs. The company offers a range of products, including anti-aging serums, treatments for ablative and micro-ablative laser procedures, chemical peels, and micro-needling, as well as therapies for scar reduction and hair re-growth support. Founded in 2014 and headquartered in Phoenix, Arizona, Omni Bioceutical Innovations collaborates with scientists and physicians to create advanced formulations featuring growth factor proteins, amino acids, and peptides. These scientifically-backed ingredients are designed to nourish the skin, promote collagen and elastin production, and enhance overall skin and hair health. The company primarily serves professionals in the global medical aesthetic market through online channels.

Hildeez Enterprises is a manufacturer of post-surgical recovery garments intended for patients who undergo surgical procedures of the knee, hip, or shoulder. The recovery garments provide modesty for patients in a hospital setting instead of having to 'bear it all' using the traditional gowns. The company was founded in 2010 and based in Peoria, Arizona.

Verve Medical, Inc. is an early-stage medical device company focused on developing innovative trans-urethral renal denervation devices aimed at treating treatment-resistant hypertension and related conditions. These devices work by targeting the sympathetic nervous system to effectively lower systolic blood pressure. By reducing hypertension, Verve Medical's technology aims to decrease the risks associated with stroke, heart disease, and cardiovascular diseases, thereby improving patient outcomes on a global scale.

RightBio Metrics Inc. specializes in fluid measurement technologies aimed at improving healthcare delivery. Founded in 2005 by physicians with backgrounds in gastroenterology and emergency medicine, the company addresses the critical issue of accurately measuring biofluids to enhance medical treatment efficiency while minimizing costs. Its flagship products include RightpH, a pH measurement technology that aids clinicians in tube placement decisions, and RightSpot, a non-invasive diagnostic device designed to verify gastric acidity for proper placement of nasogastric feeding and suction tubes. Additionally, the RightLevel device provides pH readings from gastric fluid, while the RightSpot Infant is specifically tailored for assessing gastric acidity in neonates. These innovations are intended to ensure safer patient care by reducing the risks associated with tube misplacement, thereby allowing healthcare providers to make informed clinical decisions. RightBio Metrics is headquartered in Scottsdale, Arizona.

Arizona Medical Systems, LLC (AMS) is a medical device company established through a collaboration involving Dr. Richard Heuser, MediCoventures, and BioAccel. The company focuses on developing innovative technologies to enhance medical procedures, particularly in the field of vascular access. Its flagship product, the Punctual Guidewire™, aims to streamline the process of obtaining rapid vascular access for physicians, ultimately leading to improved patient outcomes. By addressing key issues such as waste reduction, cost minimization, and decreased blood loss associated with traditional vascular access methods, AMS positions itself to meet the growing demand for advanced cardiovascular technologies.

Nasseo, Inc. is a medical device company based in Peoria, Arizona, specializing in the development and manufacture of dental and orthopedic implant systems. Established in 2012, the company has pioneered next-generation nanotube implant surface technology, known as TiArray, which modifies the natural oxide layer of implant materials to create a uniform nanotube array. This innovative technology has demonstrated benefits such as stronger bonding, faster healing, and improved soft tissue responses, particularly beneficial for patients with circulatory issues, including diabetics and smokers. Nasseo's flagship product, the TiArray Dental Implant, has received FDA approval, and the company plans to initiate post-market clinical trials. Additionally, Nasseo is working on a Titanium-PEEK hybrid interbody fusion device that incorporates the TiArray technology, further enhancing treatment options for healthcare professionals and their patients worldwide.

Yolia Health, based in Mexico City, specializes in developing innovative medical equipment aimed at preserving, restoring, and enhancing vision. The company has created The True Vision Treatment (TVT), a non-invasive solution designed to address common vision issues such as presbyopia, myopia, and hyperopia. TVT allows patients to self-administer treatment at home using a combination of customized contact lenses and specially formulated eye drops. After only five days of treatment, patients can typically cease using both the contact lenses and eye drops, as well as their reading glasses, for up to 12 months before requiring re-treatment. Notably, Yolia's approach not only corrects near vision but also improves distance vision, distinguishing it from other alternatives on the market. The company is actively seeking sophisticated investors and industry partners to further its mission.

TinyKicks is a technology company based in Irvine, California, founded in 2014 by France Helfer. The company specializes in developing a wireless smart sensor system that captures fetal movement to promote healthy pregnancy outcomes. Its flagship product, the TinyKicks eMotion fetal activity monitor, is a wearable device that detects and distinguishes between the baby's kicks and the mother's movements. This continuous monitoring system automatically uploads data to the user's smartphone, allowing pregnant women to track their baby's activity. By leveraging machine learning algorithms, TinyKicks can identify abnormal fetal movement patterns, alerting users to potential complications and thereby reducing the costs associated with pregnancy-related issues.

Nasseo, Inc. is a medical device company based in Peoria, Arizona, specializing in the development and manufacture of dental and orthopedic implant systems. Established in 2012, the company has pioneered next-generation nanotube implant surface technology, known as TiArray, which modifies the natural oxide layer of implant materials to create a uniform nanotube array. This innovative technology has demonstrated benefits such as stronger bonding, faster healing, and improved soft tissue responses, particularly beneficial for patients with circulatory issues, including diabetics and smokers. Nasseo's flagship product, the TiArray Dental Implant, has received FDA approval, and the company plans to initiate post-market clinical trials. Additionally, Nasseo is working on a Titanium-PEEK hybrid interbody fusion device that incorporates the TiArray technology, further enhancing treatment options for healthcare professionals and their patients worldwide.

Stimwave LLC is a medical device company focused on developing, manufacturing, and marketing wireless microsize injectable devices for neurology applications. The company's product offerings include the Freedom SCS System, a spinal cord stimulator designed to alleviate chronic low back and leg pain, and the StimQ PNS System, a peripheral nerve stimulator that addresses chronic pain by targeting specific peripheral nerves. Originally incorporated as Neural Micro Incorporated in 2010, Stimwave LLC is headquartered in Pompano Beach, Florida.